RankAlpha logo
Back to Rankings

WAT

WatersC
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
Current thesis
The bull case is that Q1 already showed the combined company can beat on both core Waters demand and the newly acquired BD assets: organic constant-currency growth was 11%, the acquired businesses delivered $520 million of owned-period revenue versus guidance that was $40 million lower, and management raised full-year revenue and EPS guidance while pointing to early revenue-synergy traction [#SEC-8K-2026-05-05].
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.1.
What can break
China demand, procurement restrictions, tariff uncertainty, and local competition remain explicit risks in company filings [#10-K-2026-02-23][#SEC-10Q-2026-05-12].
Momentum
36
Value
60
Sentiment
51
Setup hits (3d)
— · Net —
AI TargetsBase $395.00 · Bull $425.00 · Bear $320.00
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-18 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net —
Target $416.18
Why
Momentum36 · Δ7d -22.9
Value60 · Δ7d -0.1
Sentiment51 · Δ7d -1.4
So what
Balanced signals. Wait for confirmation before sizing up.
Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits
Lead driver: Value · See fundamentals
Momentum
36
26% active weight
Current posture
7d trendFlat
Δ7d
-22.9
Δ21d
-47.0
Value
60
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
+0.5
Sentiment
51
34% active weight
Current posture
7d trendSoftening
Δ7d
-1.4
Δ21d
-0.3
Why this grade

Composite grade C. Momentum 36.4 / Value 59.5 / Sentiment 51.3

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$36.23B
Beta
1.18
Shares Out
98.19M
P/E (TTM)
36.3
P/S (TTM)
7.57
P/FCF (TTM)
39.04
Rev YoY
+91.5%
EPS YoY
-143.1%
Gross Margin
+50.2%
Op Margin
+26.5%
Net Debt
$903.25M
Current Ratio
1.79
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology